These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 6305816

  • 1. Spironolactone- and canrenone-induced changes in hepatic (Na+,K+)ATPase activity, surface membrane cholesterol and phospholipid, and fluorescence polarization in the rat.
    Miner PB, Sneller M, Crawford SS.
    Hepatology; 1983; 3(4):481-8. PubMed ID: 6305816
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Do canrenone and 6,7-dihydroxylated derivatives compete with ouabain at the same site on Na,K-ATPase?
    Tal DM, Karlish SJ.
    Mol Pharmacol; 1988 Sep; 34(3):245-9. PubMed ID: 2843743
    [Abstract] [Full Text] [Related]

  • 4. Role of liver plasma membrane fluidity in the pathogenesis of estrogen-induced cholestasis.
    Smith DJ, Gordon ER.
    J Lab Clin Med; 1988 Dec; 112(6):679-85. PubMed ID: 3193023
    [Abstract] [Full Text] [Related]

  • 5. Alterations of hepatic Na+,K+-atpase and bile flow by estrogen: effects on liver surface membrane lipid structure and function.
    Davis RA, Kern F, Showalter R, Sutherland E, Sinensky M, Simon FR.
    Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4130-4. PubMed ID: 212735
    [Abstract] [Full Text] [Related]

  • 6. Increase in the basal tone of guinea pig thoracic aorta induced by ouabain is inhibited by spironolactone canrenone and potassium canrenoate.
    Sorrentino R, Cirino G, Calignano A, Mancuso F, Sorrentino L, Andriuoli G, Pinto A.
    J Cardiovasc Pharmacol; 1996 Oct; 28(4):519-25. PubMed ID: 8891876
    [Abstract] [Full Text] [Related]

  • 7. Spironolactone and canrenoate-K: relative potency at steady state.
    Ramsay L, Asbury M, Shelton J, Harrison I.
    Clin Pharmacol Ther; 1977 May; 21(5):602-9. PubMed ID: 858213
    [Abstract] [Full Text] [Related]

  • 8. Effects of canrenone on blood pressure in rats with reduced renal mass.
    Pamnani MB, Whitehorn WV, Clough DL, Haddy FJ.
    Am J Hypertens; 1990 Mar; 3(3):188-95. PubMed ID: 2157466
    [Abstract] [Full Text] [Related]

  • 9. Substance P induces alterations on cerebral lipids involved in membrane fluidity.
    Catalán RE, Martínez AM, Aragonés MD, Robles A, Miguel BG.
    Biochem Biophys Res Commun; 1987 Apr 14; 144(1):232-7. PubMed ID: 2437908
    [Abstract] [Full Text] [Related]

  • 10. The effect of ethanol on hepatic sodium plus potassium activated adenosine triphosphatase activity in the rat.
    Ricci RL, Crawford SS, Miner PB.
    Gastroenterology; 1981 Jun 14; 80(6):1445-50. PubMed ID: 6262182
    [Abstract] [Full Text] [Related]

  • 11. Alterations in the physicochemical properties of renal cortical membranes in rats with experimental cirrhosis of the liver.
    Pérez-Rodrigo P, Gavilanes F, López-Novoa JM.
    Arch Int Physiol Biochim; 1990 Dec 14; 98(6):371-6. PubMed ID: 1705776
    [Abstract] [Full Text] [Related]

  • 12. Cryptic adenosine triphosphatase activities in plasma membranes of CCl4-cirrhotic rats. Its modulation by changes in cholesterol/phospholipid ratios.
    Yahuaca P, Amaya A, Rojkind M, Mourelle M.
    Lab Invest; 1985 Nov 14; 53(5):541-5. PubMed ID: 2997543
    [Abstract] [Full Text] [Related]

  • 13. Modulation by S-adenosyl-L-methionine of hepatic Na+,K+-ATPase, membrane fluidity, and bile flow in rats with ethinyl estradiol-induced cholestasis.
    Boelsterli UA, Rakhit G, Balazs T.
    Hepatology; 1983 Nov 14; 3(1):12-7. PubMed ID: 6295906
    [Abstract] [Full Text] [Related]

  • 14. Spironolactone and potassium canrenoate in normal man.
    Ramsay L, Shelton J, Harrison I, Tidd M, Asbury M.
    Clin Pharmacol Ther; 1976 Aug 14; 20(2):167-77. PubMed ID: 780038
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of spironolactone, canrenone and canrenoate-K on cytochrome P450, and 11beta- and 18-hydroxylation in bovine and human adrenal cortical mitochondria.
    Cheng SC, Suzuki K, Sadee W, Harding BW.
    Endocrinology; 1976 Oct 14; 99(4):1097-106. PubMed ID: 976190
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The interaction of canrenone with the Na+,K+ pump in human red blood cells.
    Garay RP, Diez J, Nazaret C, Dagher G, Abitbol JP.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 May 14; 329(3):311-5. PubMed ID: 2991778
    [Abstract] [Full Text] [Related]

  • 19. Smoking-induced alterations in platelet membrane fluidity and Na(+)/K(+)-ATPase activity in chronic cigarette smokers.
    Padmavathi P, Reddy VD, Maturu P, Varadacharyulu N.
    J Atheroscler Thromb; 2010 Jun 30; 17(6):619-27. PubMed ID: 20154447
    [Abstract] [Full Text] [Related]

  • 20. Ethinylestradiol administration selectively alters liver sinusoidal membrane lipid fluidity and protein composition.
    Rosario J, Sutherland E, Zaccaro L, Simon FR.
    Biochemistry; 1988 May 31; 27(11):3939-46. PubMed ID: 3415965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.